Life

Health, science, climate, and society-focused reporting.

Examining the Impact of Trump's Executive Actions on LGBTQ+ Health

This overview details the Executive Actions from the Trump administration that may affect the health of LGBTQ+ individuals, highlighting their potential implications.

editorial-staff Apr 10

Life

Analysis of Domestic HIV Funding in President Trump's FY2027 Budget Proposal

An overview of the proposed funding for domestic HIV programs in President Trump's FY27 budget request highlights key initiatives aimed at addressing the epidemic.

editorial-staff Apr 10

Life

Concerns Raised Over Insufficient Action Against Illegal Vape Market

A recent GAO report indicates that the Justice Department's measures against illegal vaping products are inadequate, prompting calls for enhanced regulations from advocates.

editorial-staff Apr 10

Life

Replimune's Skin Cancer Drug Faces Another FDA Rejection

Replimune's cancer drug candidate has been rejected by the FDA for the second time, raising questions and discussions within the medical community.

editorial-staff Apr 10

Life

Pharmaceutical Industry Updates: Recent Hires, Departures, and Promotions

The pharmaceutical sector continues to see movement with various new hires, departures, and promotions. Here’s a summary of the latest changes in personnel.

editorial-staff Apr 10

Life

Trump Administration Recognizes Major Miscalculation in Medicaid Fraud Claims

This week, the Trump administration conceded to a significant miscalculation in the data it utilized to support a fraud investigation into New York's Medicaid program.

editorial-staff Apr 10

Life

Exploring New Frontiers in Biotech: CAR-T and GSK's Strategic Shift

Recent developments in biotech highlight the potential of CAR-T therapies in treating autoimmune diseases, alongside GSK's decision to phase out leucovorin.

editorial-staff Apr 10

Life

Pharmaceutical Insights: Affordable Obesity Drugs in India and Rising Demand for Estrogen Patches

Recent reports highlight the availability of low-cost generic obesity medications in India, alongside a notable increase in the demand for estrogen patches, as shared in the Pharmalittle newsletter.

editorial-staff Apr 10

Life

GSK Discontinues Leucovorin Once More

In the latest health news, GSK has announced another departure from leucovorin, alongside updates on a revised ACIP charter and issues related to sports betting and gambling addiction.

editorial-staff Apr 10

Life

Exploring the Allure of Sports Betting Apps

In the latest STATus Report, Alex Hogan examines the strategies sports betting apps use to attract users, sharing his own experiences with enticing promotions.

editorial-staff Apr 10

Life

Reflections from a MAHA Activist: Rebuilding Trust in Public Health

A MAHA advocate shares insights from their experience within the public health sector, expressing a desire to restore trust in the medical community.

editorial-staff Apr 10

Life

Insights from the MAHA Movement for Public Health

Monica L. Wang discusses the significance of social capital developed by the MAHA movement and its implications for public health.

editorial-staff Apr 10

Life

Health Officials Emphasize the Need for Portable Medical Records

Top health officials are stressing the importance of making medical records more portable. Currently, health tech companies are pursuing this goal on a voluntary basis.

editorial-staff Apr 9

Life

CDC Vaccine Panel Undergoes Changes Amid Legal Challenges and Political Influence

Recent modifications to the CDC vaccine panel are reportedly a response to ongoing lawsuits and the influence of RFK Jr.'s health department, which seeks to reduce childhood vaccination recommendations.

editorial-staff Apr 9

Life

Exploring the Resurgence of Exon Science and Biotech Challenges

In this week's episode of 'The Readout LOUD', we delve into the renewed interest in exon science, the concerns facing biotech venture capitalists, and the upcoming leadership changes at PhRMA.

editorial-staff Apr 9

Life

Rising Uninsured Rates Mark a Shift in Health Coverage Trends

In a concerning development, the number of uninsured individuals increased in 2024, marking the first rise since 2019, according to KFF's analysis of ACS data.

editorial-staff Apr 9

Life

Democrats Propose New Health Care Plan Amid Rising Costs

With health care costs on the rise, Democrats are prioritizing affordability in their latest health care strategy.

editorial-staff Apr 9

Life

CAR-T Therapy Continues to Impress Autoimmunity Researchers Five Years After Lupus Breakthrough

Five years post-lupus breakthrough, CAR-T therapy shows promise in autoimmune disease remissions, sparking increased research and investment.

editorial-staff Apr 9

Life

FDA's Rejection of AI Device Deregulation Proposal Signals Ongoing Safety Concerns

The FDA has rejected a proposal aimed at easing regulations on specific AI devices, emphasizing the agency's commitment to safety and efficacy in health technology.

editorial-staff Apr 9

Life

PhRMA's Steve Ubl to Depart After Over a Decade of Leadership

Steve Ubl, the CEO of PhRMA, will resign at the end of the year, marking a notable shift in the pharmaceutical lobbying arena after leading for more than ten years.

editorial-staff Apr 9